Introduction
The digestive system serves as a critical entry point for microorganisms that have co-evolved with humans, establishing a symbiotic balance vital for bodily functions and processes (1). The gastrointestinal microbiome is an assembly of microbes, including commensal, symbiotic, and pathogenic organisms, which occupy the body's space and play a pivotal role in health and disease (2).
The oral and gastrointestinal microbiomes constitute the mouthgut axis, sharing immunological tolerance mechanisms. These mucosal surfaces interact with antigens and external molecules through ingestion or inhalation (3).
The focus of this study is the gastrointestinal tract, which has specialized functions and contains distinct microbial communities. These communities are instrumental in food digestion, nutrient absorption, waste elimination, and are key to the development and maintenance of the immune response (4).
The gut microbiome boasts the highest diversity within the human body, with the oral microbiome ranking second. Despite their differences, they share genetic elements (5). The intestinal microbiome comprises approximately 100 trillion microorganisms, predominantly from the phyla Firmicutes, Bacteroidetes, and Actinobacteria. Common genera include Bacteroides and Bifido- bacterium, while Lactobacilli and Streptococci are found in smaller proportions (6).
In contrast, the oral microbiome consists of roughly 770 prokaryotic species, along with fungi, viruses, and protozoa. Its dynamism stems from the variety of niches within the oral cavity, such as teeth, tongue, and gums. Its primary phyla include Firmicutes, Bacteroidetes, Proteobacteria, Actino- bacteria, Spirochaetes, and Fusobacteria, existing in biofilms (7).
A prior study, utilizing a meta-analysis of 1,473 samples from the oral cavity and 2,182 intestinal metagenomes, demonstrated significant genetic diversity within the microbiome. It also found shared genomic sequences between these two anatomical sites. The research revealed that half of the genes in a metagenomic sample are unique to an individual, suggesting that personal microbiomes can be distinguished by certain rare microbial species exclusive to each person (5).
Despite the connection between oral and gut microbiomes, the extent of the influence of oral bacteria on systemic health remains complex. Further investigation is necessary to elucidate the implications of periodontal disease on overall health. This study aims to assess the correspondence, diversity, and bacterial abundance in oral and faecal samples from healthy adults, employing metagenomic analysis based on 16S rRNA.
While the oral and gut microbiomes are interlinked, the precise influence of oral bacteria on systemic health is intricate and warrants additio- nal research to grasp the full impact of periodontal disease on general well-being. Variations in the array of bacteria associated with gum disease in oral and faecal samples from healthy individuals could indicate notable differences in microbial composition related to oral health status. Conse- quently, the aim of this study was to estimate the correspondence, diversity, and bacterial abundance in oral and faecal samples from healthy adult subjects, through a metagenomic analysis based on 16S rRNA.
Methods
This is a study based on a secondary analy- sis of previously published sequences.
Sequeces search
To locate sequences for analysis, a systematic search was performed in the MGNIFY database of the European Molecular Biology Laboratory (EMBL) and the National Library of Medicine's (NLM) BioProject using the terms "human gut," "oral," and "metagenome." The search specifically targeted amplicon samples that had FASTQ files readily accessible for download. Out of three studies identified, the study conducted in China featured the most extensive collection of samples available for download. Table 1 provides a summary of the identified studies, including their country of origin, as well as the type and quantity of samples available in each.
The study titled "Human Oral-Gut Microbiota Axis in Health" utilized amplicon-based assays, adopted the Illumina MiSeq sequencing approach, and incorporated associated metadata to identify participants who fit the criteria for the present investigation. Details of the original study from which the sequences were derived are accessible at (NCBI BioProject PRJNA834584) (https://www.ncbi.nlm. nih.gov/bioproject/PRJNA834584). Table 1 outlines the principal attributes of this foundational research. Table 2 presents the characteristics of the study from which the sequences were sourced.
Selection criteria
Samples were selected from participants who fulfilled the following inclusion criteria: age range of 23-65 years, body mass index (BMI) between 18.5-24.9 kg/m², a Bristol stool scale score of 4, absence of antibiotic usage, abstention from alcohol consumption, non-smoking status, systolic blood pressure below 120 mm Hg, diastolic blood pressure under 80 mm Hg, and waist circumference less than 87 cm for males and under 80 cm for females. A total of six women conformed to these specifications, yielding 12 samples comprising one faecal sample and one oral rinse sample per participant. These are detailed in Table 3.
Data analysis
Upon acquisition of the sequences in. fastq format, the SHAMAN application (https:// shaman.pasteur.fr/), an open-access resource for differential metagenomic data analysis, was employed. This platform facilitates both statistical evaluation and graphical representation of the findings. SHAMAN's bioinformatic workflow utilizes Vsearch for sequence processing and the DESeq2 R package for Statistical analysis, which employs a Generalized Linear Model to detect features with differential abundance across comparative groups.
The analytical procedure within SHAMAN encompasses several critical steps: 1) Operational Taxonomic Unit (OTU) selection, which includes dereplication, noise reduction, chimera elimination, and clustering. 2) Quantification of OTUs present in each sample. 3) Annotation of OTUs using a curated taxonomic reference database (9).
Subsequent to these steps, comprehensive tables and visualizations were generated for the differential analysis of the metagenomic data, focusing on 16S ribosomal RNA. The Silva database was utilized for the annotation process.
Table 1 Studies with available sequences, type of information and country of origin.
| Country | Study Title | Accession number | Sample Type | Number of Samples |
|---|---|---|---|---|
| Italy | Lifestyles and gut microbiome composition | SRP291976 | human gut metagenome | 40 |
| USA | Dysbiosis and alterations in predicted functions of the subgingival microbiome in chronic periodontitis | PRJNA269205 | human oral metagenome | 50 |
| China | Human oral-gut microbiota axis in health | PRJNA834584 | human oral metagenome | 940 |
Table 2 Characteristics of the Source Study for the Obtained Sequences.*
| BioProject | PRJNA834584 |
| Consent | Public |
| Assay Type | Amplicon |
| BioSampleModel | MIGS/MIMS/MIMARKS.human-associated, MIMARKS.survey |
| Center Name | The Chinese University Of Hong Kong |
| Collection_Date | missing |
| DATASTORE filetype | FASTQ, SRA |
| DATASTORE provider | GS, S3 |
| DATASTORE region | gs.US, s3.us-east-1 |
| Ethnicity | chinese |
| geo_loc_name_country | Hong Kong |
| geo_loc_name_country_continent | Asia |
| geo_loc_name | Hong Kong |
| Host | Homo sapiens |
| Instrument | Illumina MiSeq |
| Lat_Lon | 22.18 N 114.10 E |
| LibraryLayout | Paired |
| LibrarySelection | PCR |
| LibrarySource | Metagenomic |
| Platform | Illumina |
| ReleaseDate | 2022-10-19 |
| SRA (Sequence Read Archive) Study | SRO373282 |
*Download link of sequences:
https://www.ncbi.nlm.nih.gov/Traces/study/?uids=21597576%2C21597354%2C21597218%2C21597152%2C21597140%2C2159713 0%2C21597112%2C21596996%2C21596892%2C21596645%2C21596552%2C21596500%2C21596392%2C21596378%2C21596 339%2C21596338%2C21596301%2C21596281%2C21596270%2C21596156%2C21596150%2C21596148%2C21596088%2C215 96046%2C21596043%2C21596036&o=acc_s%3Aa#
Table 3 Sample associated characteristics.
| Run | Sample ID | Subject ID | Age | Sample type |
|---|---|---|---|---|
| SRR19047639 | HM0005_stool | HM0005 | 57 | Faecal |
| SRR19047214 | HM0005_oral | HM0005 | 57 | Oral |
| SRR19047254 | HM0109_stool | HM0109 | 23 | Faecal |
| SRR19047092 | HM0109_oral | HM0109 | 23 | Oral |
| SRR19046934 | HM0233_stool | HM0233 | 24 | Faecal |
| SRR19047038 | HM0233_oral | HM0233 | 24 | Oral |
| SRR19046926 | HM0248_stool | HM0248 | 54 | Faecal |
| SRR19047311 | HM0248_oral | HM0248 | 54 | Oral |
| SRR19047200 | HM0259_stool | HM0259 | 48 | Faecal |
| SRR19047291 | HM0259_oral | HM0259 | 48 | Oral |
| SRR19047458 | HM0388_stool | HM0388 | 65 | Faecal |
| SRR19047551 | HM0388_oral | HM0388 | 65 | Oral |
Results
The annotation success rate at the genus level reached 88.64%, resulting in the taxonomic assignment of 148 genera within the samples.
In the group analysis, the dendrogram depic- ted in Figure 1 demonstrates distinct clustering of oral and faecal samples. The oral samples distinctly aggregate within the left cluster, whereas the faecal samples are clearly grouped on the right, indicating a separation based on sample origin.
In the principal component analysis (PCA), it was determined that 68.81% of the variance within the model is attributable to the anatomical site from which the sample was obtained. Correspondingly, the principal coordinates analysis (PCoA) revealed analogous clustering of samples by anatomical site, accounting for 53.7% of the model's variance ascribed to this factor (Permanova test, p=0.003). This pattern is visually represented in Figure 2.
Among the genera annotated during the analysis, 74 displayed differential features when contrasting oral sites with faecal samples. Notably, a greater number of distinct genera were present in the faecal samples (indicated in green), as illustrated in Figure 3.
The analysis of the most abundant genera in both sample types reveals a clear dominance of the genus Bacteroides in faecal samples, accounting for 72.5% of the total. This is followed by smaller proportions of the genera _Prevotella_9, Faecali- bacterium, Streptomyces, Alistipes, Fusobacterium, Haemophilus, and Streptococcus. Conversely, oral samples are predominantly composed of Strep- tococcus, representing 46.3%, and Neisseria, at 16.9%. Other notable genera include Gemella, Fusobacterium, Haemophilus, Porphyromonas, Prevotella_7, and Streptomyces, as depicted in Figure 4.
Bacteroides predominates in faecal samples, accounting for 72.5% of the total abundance. It is followed by the genera Prevotella_9, Faecalibac- terium, Streptomyces, Alistipes, Fusobacterium, Haemophilus, and Streptococcus, albeit in smaller proportions. Conversely, oral samples exhibit a predominance of Streptococcus at 46.3% and Neisseria at 16.9%. Additional genera present in oral samples include Gemella, Fusobacterium, Haemophilus, Porphyromonas, Prevotella_7, and Streptomyces (Table 4).
With respect to the diversity within oral and faecal niches, it was found that both anatomical sites possess considerable microbiome diversity. In terms of Alpha diversity, indicative of species richness or the mean species count within a specific habitat, faecal samples demonstrated higher diversity (62.83 CI: 51.54-74.13) in comparison to oral samples (52.33 CI: 46.79-57.87); however, this difference did not reach statistical significance. Beta diversity, denoting the variation between distinct habitats, was more pronounced in faecal samples (0.67) relative to oral samples (0.43). Similarly, Gamma diversity, which represents the overall species richness across each anatomical site, was greater for faecal simples (105) than for oral samples (75).
The Shannon diversity index, which measures species abundance and evenness, presented comparable values for the two anatomical sites:
2.14 for faecal samples and 2.28 for oral samples. Simpson's diversity index, reflecting the probability that two individuals randomly selected from a sample will belong to the same species, also indicated similar trends, with faecal samples scoring 0.70 and oral samples scoring 0.82. Regarding beta diversity, which assesses the diversity between different communities, faecal samples displayed greater diversity in comparison to oral samples. These findings are summarized in Table 5.
At the species level, certain periodonto- pathogenic bacteria were identified in oral samples with varying frequencies, yet were absent in faecal samples. These included Porphyromonas gingivalis in 1 out of 6 samples, Filifactor alocis in 2 out of 6 samples, Prevotella nigrescens in all 6 samples, and Treponema denticola in 3 out of 6 samples.
Table 4 Most abundant genera from faecal and oral samples.
| Genus | Faecal Samples | Oral Samples |
|---|---|---|
| Bacteroides | 72.5% | - |
| Prevotella_9 | 8.5% | - |
| Faecalibacterium | 7.7% | - |
| Streptomyces | 7.3% | 2.1% |
| Alistipes | 2.8% | - |
| Fusobacterium | 0.5% | 7.7% |
| Haemophilus | 0.4% | 6.6% |
| Streptococcus | 0.3% | 46.3% |
| Neisseria | - | 16.9% |
| Gemella | - | 8.3% |
| Porphyromonas | - | 6.2% |
| Prevotella_7 | - | 5.9% |
Discussion
In this study, the absence of periodontopathogenic bacteria in faecal samples from healthy adult women was noted. This finding contrasts with other research that suggests a possible translocation of such bacteria between anatomical sites, especially given their location within the same gastrointestinal tract. However, it is important to consider that the small sample size in this study may limit the generalizability of these Results. Therefore, it would be prudent to investigate this hypothesis further in a larger cohort to determine if the observed pattern holds true across a broader population.
Consistent with the findings of this investigation, other researchers have reported that periodontopathic bacteria are typically scarce or absent in the faecal samples of healthy individuals, indicating a limited transfer of bacteria from the oral cavity to the gut. Notably, some studies have detected minor infiltration of oral bacteria, predominantly streptococci, into the intestinal environment. This occurrence appears to be independent of the participants' periodontal health status, suggesting that while certain oral microbes may migrate to the gut, the existence of periodontal disease does not appear to significantly influence this migration (10). The implications of these observations are multifaceted and underscore the complexity of microbial interactions within the human body, as well as the potential barriers to bacterial movement between distinct biomes. Further research is warranted to elucidate the mechanisms governing microbial translocation and its impact on systemic health.
The relationship between periodontal bacteria and inflammatory bowel diseases, such as Crohn's disease, is an area of growing inter- est within the medical community. Notably, the prevalence of Porphyromonas gingivalis has been observed to be significantly higher in faecalsamples from patients with Crohn's disease. This observation was made through a detailed analysis of taxonomic assignment files derived from the Crohn’s Disease Viral and Microbial Metagenome Project (PRJEB3206). The study revealed that the abundance of Porphyromonadaceae, the bacterial family to which Porphyromonas gingivalis belongs, was markedly elevated in the faecal samples of individuals diagnosed with Crohn's disease when compared to those of healthy control volunteers. This finding points to a potential association between the presence of Porphyromonas gingivalis and the manifestation of clinical symptoms associated with Crohn's disease (11). It raises questions about the role of oral-derived microbes in the pathogenesis of gastrointestinal disorders and whether they may contribute to or exacerbate inflammatory processes in the gut. The mechanisms by which these periodontal pathogens might influence the development or progression of Crohn's disease remain to be fully understood. However, it is hypothesized that the systemic inflammation triggered by periodontal infections could play a role in the intestinal inflammation characteristic of Crohn's disease.
Given the complexity of microbial ecosys- tems and their interactions with host immunity, further research is essential to clarify the pathways through which periodontal bacteria may impact gut health. Such studies should consider the microbial interplay at various body sites, the immune responses elicited by these microbes, and the environmental factors that might facilitate their translocation. Understanding these dynamics could lead to novel therapeutic strategies for managing inflammatory bowel diseases and highlight the importance of maintaining oral health for overall well-being.
The intricate relationship between the oral and gut microbiomes is increasingly recognized as a critical component of systemic health. Previous studies have demonstrated correlations between faecal microbiota and oral bacteria in individuals with periodontal disease, supporting a potential oral-gut axis mediated by microbial dynamics. Notably, Fusobacterium nucleatum, a keystone pathogen in periodontitis, is frequently enriched in faecal samples of affected individuals, highlighting its dual role in oral dysbiosis and potential systemic effects (12). This enrichment underscores the hypothesis that periodontal pathogens may influence gut microbiota composition, possibly through direct translocation or immune-mediated pathways.
The presence of oral microbial taxa in faecal samples, although limited, provides insights into how oral dysbiosis might contribute to systemic health issues. While oral taxa typically represent a minor proportion of the gut microbiota, their detection in faecal samples suggests transient colonization or direct seeding from the oral cavity, particularly in disease states. Studies have shown that periodontal conditions, such as gingivitis and periodontitis, are associated with specific microbial signatures, including increased salivary abundance of Aggregatibacter actinomycetemco- mitans, Parvimonas micra, and Fretibacterium species, which correlate with clinical markers such as deep periodontal pockets and inflam- mation (12).
The microbial diversity observed in saliva samples from periodontitis patients also reveals significant dysbiosis. The increased biodiver- sity, while counterintuitive, reflects the presence of pathogenic bacteria that disrupt the ecologi- cal balance of the oral microbiome. Periodontopathic species such as Porphyromonas gingivalis, Treponema denticola and Prevotella intermedia dominate in disease states, contrasting with the relative abundance of health-associated genera such as Streptococcus and Neisseria in healthy individuals (13, 14). These findings highlight the dynamic nature of the oral microbiome and its role in maintaining oral and systemic health.
Comparisons between the oral and gut microbiomes in healthy individuals and those with periodontal disease further reveal distinct microbial compositions and diversity metrics. The Shannon diversity index, a measure of species richness and evenness, shows similar values between oral and faecal samples, indicating comparable levels of microbial diversity at these sites. However, beta diversity analyses reveal that faecal samples typically exhibit greater inter-individual variability, likely reflecting the influence of diet, host genetics, and systemic health factors (16). This aligns with findings that gut microbiota are more dynamic and responsive to external factors compared to the relatively stable oral microbiota.
Interestingly, while some pathogenic bacteria such as Fusobacterium nucleatum are enriched in both oral and faecal samples of periodontitis patients, other periodontopathic species remain exclusive to the oral cavity. This exclusivity suggests that while certain bacteria may traverse the gastrointestinal tract, others rely on the unique ecological niches of the oral environment for survival and proliferation (12, 19, 20). This distinction emphasizes the importance of niche-specific factors in shaping microbial communities.
Methodological advancements, such as the application of SHAMAN for metagenomic analysis, have enhanced our understanding of these microbiomes. This tool has been validated in studies of microbiomes across various primate body sites, demonstrating the uniqueness of the oral microbiome and its significant divergence from other body sites (15). Such tools allow for more nuanced analyses of microbial contributions to health and disease, particularly through metrics like the contribution spectrum, which quantifies the impact of specific taxa on health outcomes (17).
The interplay between oral and gut microbiomes has profound implications for systemic health.
Oral dysbiosis, characterized by increased diversity and the presence of periodontopathic species, may not only exacerbate periodontal disease but also influence gut health and systemic inflammation. The detection of shared microbial taxa between these niches suggests potential mechanisms of microbial exchange, whether through swallowing, immune interactions, or systemic circulation.
In Conclusions , this study corroborates existing evidence that the oral and gut microbiomes, while distinct, are interconnected. Differen- ces in microbial composition and diversity metrics between these sites reflect their unique ecological roles and interactions with host physiology. The findings also underscore the exclusivity of periodontopathic species to the oral cavity, emphasizing the localized nature of periodontal disease. Future research should focus on unravelling the mechanistic pathways linking oral dysbiosis to gut health and systemic diseases, with the potential to identify novel therapeutic targets for managing periodontal and systemic conditions.
Author contribution statement
All authors contributed to the conduct of this study.
Conceptualization and design: A.J.E. and B.P.P.
Literature review: A.J.E.
Methodology and validation: A.J.E and N.R.F.
Data analysis and interpretation: A.J.E and N.R.F.
Writing-original draft preparation: A.J.E., N.R.F. and B.P.P.
Writing-review & editing: A.J.E., N.R.F. and B.P.P.
Supervision: B.P.P.
Final approval of the manuscript: A.J.E., N.R.F. and B.P.P.

















